...
首页> 外文期刊>Tissue antigens. >Loss of heterozygosity at 6p21 underlying HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
【24h】

Loss of heterozygosity at 6p21 underlying HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.

机译:在中国原发性食管鳞状细胞癌中,HLA I类下调​​的6p21杂合度丧失。

获取原文
获取原文并翻译 | 示例
           

摘要

Loss or downregulation of human leukocyte antigen (HLA) class I molecules is a widespread mechanism used by tumor cells to avoid tumor recognition by cytotoxic T lymphocytes favoring tumor immune escape. Multiple molecular mechanisms are responsible for these altered HLA class I tumor phenotypes, such as the loss of heterozygosity (LOH) at chromosome region 6p21.3. In this study, we used immunohistological techniques with a highly selective panel of anti-HLA monoclonal antibodies to analyze the expression of HLA class I molecules in 84 formalin-fixed, paraffin-embedded section and 49 frozen-fresh tissues of primary esophageal squamous cell carcinomas (pESCC) from Chinese patients. To elucidate the underlying mechanism of HLA class I loss or downregulation, we also analyzed LOH of previously selected microsatellite markers located in chromosomes 6 and 15 by polymerase chain reaction. DNA was obtained from frozen-fresh tumor tissues and surrounding stroma to define the LOH associated with chromosomes 6p21 and 15q21. Our results showed that HLA-A, HLA-B/C, HLA class I heavy chain, beta2-microglobuline, and HLA class I complex were lost or downregulated in pESCC (P<0.0001), and were moderately associated with the microsatellite alterations in HLA class I gene regions, correlated with patients' age, tumor's location, and stage, and indicated that LOH at 6p21.3 is a frequent mechanism that leads to HLA class I abnormalities in pESCC.
机译:人白细胞抗原(HLA)I类分子的丢失或下调是肿瘤细胞广泛使用的机制,可避免被有利于肿瘤免疫逃逸的细胞毒性T淋巴细胞识别肿瘤。多种分子机制是造成这些HLA I类肿瘤表型改变的原因,例如6p21.3染色体区域杂合性(LOH)的丧失。在这项研究中,我们使用具有高度选择性的抗HLA单克隆抗体的免疫组化技术分析了84例福尔马林固定,石蜡包埋的切片和49例新鲜食管鳞状细胞癌中HLA I类分子的表达(pESCC)来自中国患者。为了阐明HLA I类丢失或下调的潜在机制,我们还通过聚合酶链反应分析了位于6号和15号染色体上的先前选定的微卫星标记的LOH。从冷冻的新鲜肿瘤组织和周围基质中获得DNA,以定义与染色体6p21和15q21相关的LOH。我们的结果表明,pESCC中的HLA-A,HLA-B / C,HLA I类重链,β2-微球蛋白和HLA I类复合物丢失或下调(P <0.0001),并且与HLA-A,HLA-B / C,HLA-B / C,HLA-B / C,HLA-B / C,HLA-B / C,HLA-B / C复杂。 HLA I类基因区域与患者的年龄,肿瘤的位置和分期有关,并表明6p21.3的LOH是导致pESCC中HLA I类异常的常见机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号